The global intellectual property ecosystem for insulin and its public health implications: an observational study

[摘要]

Background

Lack of access to insulin and poor health outcomes are issues for both low and high income countries. This has been accompanied by a shift from relatively inexpensive human insulin to its more expensive analogs, marketed by three to four main global players. Nonetheless, patent-based market exclusivities are beginning to expire there for the first generation insulin analogs. This paper adds a global dimension to information on the U.S. patent landscape for insulin by reviewing the patent status of insulins with emphasis on the situation outside the US and Europe.

[学科分类] 药理学

[关键词] Patent;Intellectual property;Pharmaceutical policy;Generic medicine